Estimates of the frequency of pancreatic metastases vary widely. At autopsy, the pancreas has been found to be a site of metastasis in 3-12% of patients with malignant tumors [1][2][3]. However, the occurrence of resectable metastasis to the pancreas is less frequent because many patients already have widespread disease at the time of diagnosis of pancreatic metastasis. Only 0.5-3.0% of patients who have undergone pancreatic resection demonstrated metastatic disease [4][5][6]. Surgical management of pancreatic metastasis is poorly defined because in the past the operative risks of pancreatic surgery were too high to justify [7]. Recent improvements in morbidity and mortality after pancreatic resection allow for radical surgery with curative intent [4][5][6]. Primary tumors that give rise most frequently to metastases to the pancreas include renal cell carcinoma, colorectal, breast, and lung cancers; pancreatic metastasis from sarcomas is extremely rare. Herein we report a case of very rare synchronous solitary metastasis to the pancreas from malignant fibrous histiocytoma (MFH, a most common type of soft-tissue sarcoma) [8,9]. Moreover, we review the literature to discuss the appropriate management of pancreatic metastasis from musculoskeletal sarcomas [10-16].A 62-year-old woman was referred to our hospital for evaluation of jaundice. Her medical history was unremarkable. The patient did not consume any medications. She denied smoking and alcohol intake. There was no family history of pancreatic disease or cancer. On admission, the patient was afebrile with stable vital signs. The abdomen was soft and slightly distended, with mild tenderness in the upper abdomen. The patient noticed a soft, nontender, palpable mass in the left lower leg. Magnetic resonance imaging (MRI) showed a 5-cm, irregularly enhanced mass in the center of the gastrocnemius muscle of the left lower leg (Fig. 1). The tumor did not involve neurovascular structures, bones, or joints. Biopsy demonstrated a polygonal or spindle cell sarcoma with prominent atypical nuclei.Laboratory test results included a white blood cell count of 7,600/mm 3 , a hemoglobin level of 10.2 g/dL, and platelets of 193,000/mm 3 . Biochemical tests demonstrated the presence of aspartate aminotransferase at